Brighthouse Financial

BHFNASDAQUSD

THESIS ALERT

Email me when the BHF thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$45.33
+$0.93 (+2.09%)Today 1M −8.51%
After hours$45.330.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$44.40
Prior regular-session close from the quote source.
$43.98–$45.78
Regular-session low and high so far today.
660.5K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 22 projected
Projected for 2027-02-22 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$41.01–$66.80
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own BHF if the 2024–25 improvement in earnings and cash proves durable rather than one-off.

BHF price history

Latest price$45.33Today+$0.93 (+2.09%)
BHF -7.13%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

4 MATERIAL PROPOSITIONS
  • Improved liability management and capital-recycling actions will convert Brighthouse’s reported profits into sustainable positive operating cash flow, enabling recurring shareholder distributions.HoldingMateriality: High

    NetCashProvidedByUsedInOperatingActivities = 259000000.0 (annual, period_end 2025) — turned positive in 2025 after prior negatives. If true, owners get a growing, reliable cash return (buybacks/dividends) and valuation expansion; if false, profits may not convert to distributable cash and the stock will be vulnerable to re-rating.

    Watch: Large adverse reserve strengthening, mortality or policyholder behavior shifts that force recurring non-cash charges or cash strain (would show up in MD&A/reserve roll-forwards before cash reverses).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    NetCashProvidedByUsedInOperatingActivities = 259000000.0 (annual, period_end 2025) — turned positive in 2025 after prior negatives.

    Open source ↗
  • The revenue jump in 2025 largely reflects realized investment gains / one-time capital transactions rather than a durable increase in recurring underwriting or fee-based margins.HoldingMateriality: High

    Revenues = 6766000000.0 (annual, period_end 2025) versus 4724000000.0 (annual, period_end 2024) — a large year-over-year jump. If revenue growth is mainly one-off, future top-line and margin weakness will follow and current earnings may not repeat; if it’s recurring, the firm has a path to sustainably higher earnings.

    Watch: MD&A or notes show the 2025 revenue increase came from recurring fee income growth and improved underwriting spreads (would indicate repeatability).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Revenues = 6766000000.0 (annual, period_end 2025) versus 4724000000.0 (annual, period_end 2024) — a large year-over-year jump.

    Open source ↗
  • Brighthouse’s cash and equity build in 2024–25 provide the capacity to fund buybacks or dividends if regulatory capital tests remain comfortable.StrengtheningMateriality: Medium

    CashCashEquivalents... = 5387000000.0 (instant, period_end 2025) — cash increased versus prior years. A commitment and ability to return capital would be the direct mechanism that turns improved results into shareholder value; lacking that, earnings improvements may not translate to a higher multiple.

    Watch: Regulatory capital requirements or rating-agency demands that force retention of capital (would show via regulatory filings or management statements).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    CashCashEquivalents... = 5387000000.0 (instant, period_end 2025) — cash increased versus prior years.

    Open source ↗
  • Brighthouse’s EPS and earnings will remain materially cyclical and sensitive to investment markets and reserve activity unless product mix shifts meaningfully toward fee-based, lower-guarantee products.StrengtheningMateriality: Medium

    EarningsPerShareDiluted swung from -18.39 (annual, 2023) to 4.64 (annual, 2024) to 5.71 (annual, 2025), with 51.3 in 2022 — illustrating large year-to-year volatility. Persistent cyclicality implies higher volatility in dividends and valuation; a clear, durable shift in product mix would lower volatility and support higher multiples.

    Watch: Sustained sales and disclosed pipeline showing growth in fee-based annuity products and lower guaranteed liabilities (would appear in sales distribution/MD&A disclosures).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    EarningsPerShareDiluted swung from -18.39 (annual, 2023) to 4.64 (annual, 2024) to 5.71 (annual, 2025), with 51.3 in 2022 — illustrating.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Improved liability management and capital-recycling actions will convert Brighthouse’s reported profits into sustainable positive operating cash flow, enabling recurring shareholder distributions. If true, owners get a growing, reliable cash return (buybacks/dividends) and valuation expansion; if false, profits may not convert to distributable cash and the stock will be vulnerable to re-rating.

The revenue jump in 2025 largely reflects realized investment gains / one-time capital transactions rather than a durable increase in recurring underwriting or fee-based margins. If revenue growth is mainly one-off, future top-line and margin weakness will follow and current earnings may not repeat; if it’s recurring, the firm has a path to sustainably higher earnings.

Brighthouse’s cash and equity build in 2024–25 provide the capacity to fund buybacks or dividends if regulatory capital tests remain comfortable. A commitment and ability to return capital would be the direct mechanism that turns improved results into shareholder value; lacking that, earnings improvements may not translate to a higher multiple.

Brighthouse’s EPS and earnings will remain materially cyclical and sensitive to investment markets and reserve activity unless product mix shifts meaningfully toward fee-based, lower-guarantee products. Persistent cyclicality implies higher volatility in dividends and valuation; a clear, durable shift in product mix would lower volatility and support higher multiples.

All standing thesis claims
Original report summary

the 2024–25 improvement in earnings and cash proves durable rather than one-off.

Evidence assessed Nov 6, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Brighthouse Financial

Where the evidence on Brighthouse Financial stands: Holding on the latest evidence (Nov 6, 2026). Of its 4 thesis points, 2 strengthening and 2 holding.

Bull case: what the evidence supports

  • Improved liability management and capital-recycling actions will convert Brighthouse’s reported profits into sustainable positive operating cash flow, enabling recurring shareholder distributions.

    sec.gov ↗

  • The revenue jump in 2025 largely reflects realized investment gains / one-time capital transactions rather than a durable increase in recurring underwriting or fee-based margins.

    sec.gov ↗

  • Brighthouse’s cash and equity build in 2024–25 provide the capacity to fund buybacks or dividends if regulatory capital tests remain comfortable.

    sec.gov ↗

  • Brighthouse’s EPS and earnings will remain materially cyclical and sensitive to investment markets and reserve activity unless product mix shifts meaningfully toward fee-based, lower-guarantee products.

    sec.gov ↗

Bear case: what would count against it

  • Large adverse reserve strengthening, mortality or policyholder behavior shifts that force recurring non-cash charges or cash strain (would show up in MD&A/reserve roll-forwards before cash reverses).

    sec.gov ↗

  • MD&A or notes show the 2025 revenue increase came from recurring fee income growth and improved underwriting spreads (would indicate repeatability).

    sec.gov ↗

  • Regulatory capital requirements or rating-agency demands that force retention of capital (would show via regulatory filings or management statements).

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Brighthouse Financial

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

OptimistFi is watching Brighthouse Financial. No break-condition checks are on record yet — they accumulate as new filings are checked.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    Brighthouse Financial filed an SEC 8-K on 2026-11-05: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Director or principal officer change.

    Brighthouse Financial filed an SEC 8-K on 2026-08-18: Director or principal officer change. It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    Brighthouse Financial filed an SEC 8-K on 2026-08-05: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Large adverse reserve strengthening, mortality or policyholder behavior shifts that force recurring non-cash charges or cash strain (would show up in MD&A/reserve roll-forwards before cash reverses).
  • MD&A or notes show the 2025 revenue increase came from recurring fee income growth and improved underwriting spreads (would indicate repeatability).
  • Regulatory capital requirements or rating-agency demands that force retention of capital (would show via regulatory filings or management statements).
  • Sustained sales and disclosed pipeline showing growth in fee-based annuity products and lower guaranteed liabilities (would appear in sales distribution/MD&A disclosures).

BHF news

Loading headlines…

Financial statements

BHF income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

BHF: quick answers

When does Brighthouse Financial (BHF) report earnings next?
Brighthouse Financial's next results are projected for February 22, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 5, 2026. Earnings calendar
What is BHF's short interest?
As of October 30, 2026, 6.7M BHF shares were sold short, 11.7% of its shares outstanding, down 1.7% from the count before. At the stock's average daily volume that is 8.8 days to cover. FINRA publishes the count twice a month. BHF short interest history
Have members of Congress traded BHF?
11 trades in BHF have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed BHF trade
Which well-known investors own BHF?
1 of the 37 well-known funds tracked here reported BHF shares in their latest 13F filing. By share of the fund's portfolio: Soros Fund Management (George Soros), 0.9%. Fund portfolios

BHF in well-known investors’ portfolios

1 of 37 funds reported BHF shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
George SorosSoros Fund Management0.87%$70.7M+31.8%Q2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.